Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

adenovirus p53 gene therapy agent

Known as: Ad-p53 vector, Ad-p53, adenovirus p53 construct 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
  • L. Li, B. Wang
  • International journal of molecular sciences
  • 2014
  • Corpus ID: 13923084
MicroRNAs play important roles in laryngeal carcinoma and other cancers. However, the expression of microRNAs in paracancerous… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
2013
2013
Induction of murine double minute 2 (MDM2) expression is thought to be a determinant of resistance to p53 gene therapy for cancer… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
2010
2010
PURPOSE The aim of this study is to determine the ability of intratumorally delivered docetaxel to enhance the antitumor activity… Expand
2007
2007
OBJECTIVE To explore the effects of adenovirus-mediated wild-type p53 gene (Ad-p53) on the reversal of multidrug resistance (MDR… Expand
2006
2006
The altered expression of both p53 and erbB2 is strongly related to the disease status and the outcome of bladder cancers. We… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
Adenovirus‐mediated wild‐type p53 gene transfer induces apoptosis in a variety of human cancer cells. Although clinical trials… Expand
2002
2002
P53-based immunization is an attractive approach to cancer immunotherapy due to the accumulation of p53 protein in tumor, but not… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Highly Cited
1999
Highly Cited
1999
  • Ishida, Chada, +4 authors Carbone
  • Clinical and experimental immunology
  • 1999
  • Corpus ID: 26673706
In this study we have tested the concept of using wild‐type p53 gene for immunotherapy of cancer. Dendritic cells (DC) were… Expand